ולוויר

Country: Iżrael

Lingwa: Ebrajk

Sors: Ministry of Health

Ingredjent attiv:

VALACICLOVIR AS HYDROCHLORIDE 500 MG

Disponibbli minn:

RAFA LABORATORIES LTD

Kodiċi ATC:

J05AB11

Għamla farmaċewtika:

FILM COATED TABLETS

Rotta amministrattiva:

PER OS

Manifatturat minn:

PHARMATHEN S.A., GREECE

Grupp terapewtiku:

VALACICLOVIR

Indikazzjonijiet terapewtiċi:

Valovir is indicated for the treatment of herpes zoster (shingles) in immunocopotent adults. Valovir accelerates the resolution of pain, it reduces the duration, and the proportion of patients with zoster-associated pain, which includes acute and post-herpetic neuralgia. The efficacy of valaciclovir in immunocompromised patients has not been established.Valovir is indicated for the treatment of the initial and recurrent genital herpes due to herpes simplex infection. Valovir is indicated for the prevention (suppression) of recurrent herpes simplex infections (herpes genitalis). Prophylaxis of cytomegalovirus infection and disease, following organ transplantation. For the treatment of cold sores (herpes labialis).

Data ta 'l-awtorizzazzjoni:

2013-05-01